Medpace Holdings SG&A Expenses 2014-2023 | MEDP
Medpace Holdings annual/quarterly sg&a expenses history and growth rate from 2014 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Medpace Holdings sg&a expenses for the quarter ending December 31, 2023 were $0.043B, a 27.28% increase year-over-year.
- Medpace Holdings sg&a expenses for the twelve months ending December 31, 2023 were $0.161B, a 22.79% increase year-over-year.
- Medpace Holdings annual sg&a expenses for 2023 were $0.161B, a 22.79% increase from 2022.
- Medpace Holdings annual sg&a expenses for 2022 were $0.131B, a 21.19% increase from 2021.
- Medpace Holdings annual sg&a expenses for 2021 were $0.108B, a 17.65% increase from 2020.
| Medpace Holdings Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $161 |
| 2022 | $131 |
| 2021 | $108 |
| 2020 | $92 |
| 2019 | $95 |
| 2018 | $76 |
| 2017 | $63 |
| 2016 | $62 |
| 2015 | $57 |
| 2014 | $40 |
| 2013 | $35 |
| Medpace Holdings Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $43 |
| 2023-09-30 | $41 |
| 2023-06-30 | $39 |
| 2023-03-31 | $38 |
| 2022-12-31 | $33 |
| 2022-09-30 | $35 |
| 2022-06-30 | $33 |
| 2022-03-31 | $29 |
| 2021-12-31 | $28 |
| 2021-09-30 | $28 |
| 2021-06-30 | $27 |
| 2021-03-31 | $26 |
| 2020-12-31 | $22 |
| 2020-09-30 | $23 |
| 2020-06-30 | $22 |
| 2020-03-31 | $25 |
| 2019-12-31 | $21 |
| 2019-09-30 | $29 |
| 2019-06-30 | $24 |
| 2019-03-31 | $21 |
| 2018-12-31 | $21 |
| 2018-09-30 | $19 |
| 2018-06-30 | $21 |
| 2018-03-31 | $16 |
| 2017-12-31 | $17 |
| 2017-09-30 | $17 |
| 2017-06-30 | $15 |
| 2017-03-31 | $15 |
| 2016-12-31 | $17 |
| 2016-09-30 | $16 |
| 2016-06-30 | $15 |
| 2016-03-31 | $14 |
| 2015-12-31 | |
| 2015-09-30 | $15 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.185B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $126.410B | 15.86 |
| Cencora (COR) | United States | $44.248B | 17.25 |
| ICON (ICLR) | Ireland | $26.054B | 24.60 |
| DiDi Global (DIDIY) | China | $22.390B | 0.00 |
| Avantor (AVTR) | United States | $16.968B | 24.98 |
| CochLear (CHEOY) | Australia | $14.783B | 0.00 |
| Revvity (RVTY) | United States | $13.383B | 23.48 |
| Natera (NTRA) | United States | $13.324B | 0.00 |
| Viatris (VTRS) | United States | $13.121B | 3.92 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.374B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.577B | 22.17 |
| Solventum (SOLV) | United States | $10.632B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.727B | 50.26 |
| Organon (OGN) | United States | $5.534B | 5.25 |
| Bausch + Lomb (BLCO) | Canada | $5.357B | 21.47 |
| Doximity (DOCS) | United States | $4.429B | 30.83 |
| PACS (PACS) | United States | $4.249B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.362B | 30.76 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $3.106B | 32.54 |
| GoodRx Holdings (GDRX) | United States | $3.024B | 115.14 |
| Progyny (PGNY) | United States | $2.623B | 45.16 |
| NovoCure (NVCR) | Jersey | $2.386B | 0.00 |
| Agilon Health (AGL) | United States | $2.295B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.244B | 8.89 |
| Teladoc Health (TDOC) | United States | $2.188B | 0.00 |
| Premier (PINC) | United States | $2.073B | 8.87 |
| BrightSpring Health Services (BTSG) | United States | $1.953B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.595B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.336B | 0.00 |
| Embecta (EMBC) | United States | $0.819B | 5.57 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.656B | 6.96 |
| Auna S.A (AUNA) | Luxembourg | $0.632B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.627B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.546B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.519B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.419B | 41.75 |
| ModivCare (MODV) | United States | $0.396B | 7.41 |
| MultiPlan (MPLN) | United States | $0.385B | 0.00 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| DocGo (DCGO) | United States | $0.325B | 17.78 |
| Ascend Wellness Holdings (AAWH) | United States | $0.289B | 0.00 |
| Sharecare (SHCR) | United States | $0.284B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.274B | 0.00 |
| Biodesix (BDSX) | United States | $0.179B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.80 |
| Oncology Institute (TOI) | United States | $0.050B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Nutex Health (NUTX) | United States | $0.037B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| OncoCyte (OCX) | United States | $0.025B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |